Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
AMMO A Pref | POWWP | Nov 18, 2024 | 21.65 | -0.45 |
AMN Healthcare Services | AMN | Nov 18, 2024 | 26.50 | +11.81 |
Amneal Pharmaceuticals A | AMRX | Nov 18, 2024 | 8.33 | -1.65 |
Ampco-Pittsburgh | AP | Nov 18, 2024 | 1.71 | +3.01 |
Amphastar Pharmaceuticals | AMPH | Nov 18, 2024 | 44.16 | -1.01 |
Amphenol | APH | Nov 18, 2024 | 69.88 | -0.91 |
Amplify Energy | AMPY | Nov 18, 2024 | 6.60 | -0.15 |
Amplify Online Retail ETF | IBUY | Nov 18, 2024 | 64.14 | +0.38 |
Amplify Transformational Data Sharing ETF | BLOK | Nov 18, 2024 | 47.85 | +1.66 |
Amplitech Group | AMPG | Nov 18, 2024 | 0.85 | -3.45 |
Amplitude A | AMPL | Nov 18, 2024 | 9.76 | +1.77 |
Amprius Technologies | AMPX | Nov 18, 2024 | 1.93 | -8.96 |
AMREP | AXR | Nov 18, 2024 | 32.17 | -0.71 |
AMTD Digital ADR | HKD | Nov 18, 2024 | 2.72 | -0.73 |
AMTD Idea Group ADR | AMTD | Nov 18, 2024 | 1.12 | -0.89 |
Amtech Systems | ASYS | Nov 18, 2024 | 5.66 | -0.88 |
Amylyx Pharmaceuticals | AMLX | Nov 18, 2024 | 5.30 | +11.34 |
AN2 Therapeutics | ANTX | Nov 18, 2024 | 1.00 | 0.00 |
Analog Devices | ADI | Nov 18, 2024 | 209.65 | +1.60 |
AnaptysBio | ANAB | Nov 18, 2024 | 18.88 | -0.63 |
Anavex Life Sciences | AVXL | Nov 18, 2024 | 7.45 | +0.07 |
Andretti Acquisition II | POLE | Nov 18, 2024 | 9.96 | 0.00 |
Andretti Acquisition II Unit | POLEU | Nov 18, 2024 | 10.09 | 0.00 |
Anebulo Pharmaceuticals | ANEB | Nov 18, 2024 | 1.53 | -3.68 |
ANEW Medical | WENA | Nov 18, 2024 | 0.73 | 0.00 |
Angel Oak Financial Strategies | FINS | Nov 18, 2024 | 12.64 | +0.08 |
Angel Oak Mortgage REIT | AOMR | Nov 18, 2024 | 9.79 | -0.10 |
Anghami | ANGH | Nov 18, 2024 | 0.77 | +3.77 |
Angi A | ANGI | Nov 18, 2024 | 1.91 | +11.05 |
AngioDynamics | ANGO | Nov 18, 2024 | 6.88 | +1.03 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.